Literature DB >> 27307571

The K1 Protein of Kaposi's Sarcoma-Associated Herpesvirus Augments Viral Lytic Replication.

Zhigang Zhang1, Wuguo Chen1, Marcia K Sanders1, Kevin F Brulois1, Dirk P Dittmer1, Blossom Damania2.   

Abstract

UNLABELLED: The K1 gene product of Kaposi's sarcoma-associated herpesvirus (KSHV) is encoded by the first open reading frame (ORF) of the viral genome. To investigate the role of the K1 gene during the KSHV life cycle, we constructed a set of recombinant viruses that contained either wild-type (WT) K1, a deleted K1 ORF (KSHVΔK1), stop codons within the K1 ORF (KSHV-K15×STOP), or a revertant K1 virus (KSHV-K1REV). We report that the recombinant viruses KSHVΔK1 and KSHV-K15×STOP displayed significantly reduced lytic replication compared to WT KSHV and KSHV-K1REV upon reactivation from latency. Additionally, cells infected with the recombinant viruses KSHVΔK1 and KSHV-K15×STOP also yielded smaller amounts of infectious progeny upon reactivation than did WT KSHV- and KSHV-K1REV-infected cells. Upon reactivation from latency, WT KSHV- and KSHV-K1REV-infected cells displayed activated Akt kinase, as evidenced by its phosphorylation, while cells infected with viruses deleted for K1 showed reduced phosphorylation and activation of Akt kinase. Overall, our results suggest that K1 plays an important role during the KSHV life cycle. IMPORTANCE: Kaposi's sarcoma-associated herpesvirus (KSHV) is the etiological agent of three human malignancies, and KSHV K1 is a signaling protein that has been shown to be involved in cellular transformation and to activate the phosphatidylinositol 3-kinase (PI3K)/Akt/mTOR pathway. In order to investigate the role of the K1 protein in the life cycle of KSHV, we constructed recombinant viruses that were deficient for K1. We found that K1 deletion viruses displayed reduced lytic replication compared to the WT virus and also yielded smaller numbers of infectious progeny. We report that K1 plays an important role in the life cycle of KSHV.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27307571      PMCID: PMC4988170          DOI: 10.1128/JVI.03102-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group.

Authors:  D F Martin; B D Kuppermann; R A Wolitz; A G Palestine; H Li; C A Robinson
Journal:  N Engl J Med       Date:  1999-04-08       Impact factor: 91.245

2.  Transcriptional regulation of the K1 gene product of Kaposi's sarcoma-associated herpesvirus.

Authors:  Brian S Bowser; Scott M DeWire; Blossom Damania
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Human herpesvirus 8 K1-associated nuclear factor-kappa B-dependent promoter activity: role in Kaposi's sarcoma inflammation?

Authors:  F Samaniego; S Pati; J E Karp; O Prakash; D Bose
Journal:  J Natl Cancer Inst Monogr       Date:  2001

4.  Suppression of tetradecanoyl phorbol acetate-induced lytic reactivation of Kaposi's sarcoma-associated herpesvirus by K1 signal transduction.

Authors:  Bok-Soo Lee; Mini Paulose-Murphy; Young-Hwa Chung; Michelle Connlole; Steven Zeichner; Jae U Jung
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy.

Authors:  D H Kedes; D Ganem
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

6.  Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus.

Authors:  H Lee; R Veazey; K Williams; M Li; J Guo; F Neipel; B Fleckenstein; A Lackner; R C Desrosiers; J U Jung
Journal:  Nat Med       Date:  1998-04       Impact factor: 53.440

7.  Immortalization of primary endothelial cells by the K1 protein of Kaposi's sarcoma-associated herpesvirus.

Authors:  Ling Wang; Dirk P Dittmer; Christine C Tomlinson; Farnaz D Fakhari; Blossom Damania
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

8.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.

Authors:  E Cesarman; Y Chang; P S Moore; J W Said; D M Knowles
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

9.  The K1 protein of Kaposi's sarcoma-associated herpesvirus activates the Akt signaling pathway.

Authors:  Christine C Tomlinson; Blossom Damania
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture.

Authors:  R Renne; W Zhong; B Herndier; M McGrath; N Abbey; D Kedes; D Ganem
Journal:  Nat Med       Date:  1996-03       Impact factor: 53.440

View more
  16 in total

1.  Kaposi's Sarcoma-Associated Herpesvirus Nonstructural Membrane Protein pK15 Recruits the Class II Phosphatidylinositol 3-Kinase PI3K-C2α To Activate Productive Viral Replication.

Authors:  Bizunesh Abere; Naira Samarina; Silvia Gramolelli; Jessica Rückert; Gisa Gerold; Andreas Pich; Thomas F Schulz
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

Review 2.  Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy.

Authors:  Dirk P Dittmer; Blossom Damania
Journal:  J Clin Invest       Date:  2016-09-01       Impact factor: 14.808

Review 3.  Modulation of oncogenic signaling networks by Kaposi's sarcoma-associated herpesvirus.

Authors:  Jason P Wong; Blossom Damania
Journal:  Biol Chem       Date:  2017-07-26       Impact factor: 3.915

4.  Kaposi Sarcoma-Associated Herpesvirus Glycoprotein H Is Indispensable for Infection of Epithelial, Endothelial, and Fibroblast Cell Types.

Authors:  Murali Muniraju; Lorraine Z Mutsvunguma; Joslyn Foley; Gabriela M Escalante; Esther Rodriguez; Romina Nabiee; Jennifer Totonchy; David H Mulama; Joshua Nyagol; Felix Wussow; Anne K Barasa; Michael Brehm; Javier Gordon Ogembo
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

Review 5.  Kaposi's Sarcoma-Associated Herpesvirus (KSHV)-Associated Disease in the AIDS Patient: An Update.

Authors:  Dirk P Dittmer; Blossom Damania
Journal:  Cancer Treat Res       Date:  2019

6.  Whole-genome sequencing of Kaposi sarcoma-associated herpesvirus (KSHV/HHV8) reveals evidence for two African lineages.

Authors:  Razia Moorad; Angelica Juarez; Justin T Landis; Linda J Pluta; Megan Perkins; Avery Cheves; Dirk P Dittmer
Journal:  Virology       Date:  2022-02-02       Impact factor: 3.616

Review 7.  Kaposi sarcoma.

Authors:  Ethel Cesarman; Blossom Damania; Susan E Krown; Jeffrey Martin; Mark Bower; Denise Whitby
Journal:  Nat Rev Dis Primers       Date:  2019-01-31       Impact factor: 52.329

Review 8.  Manipulation of the host cell membrane by human γ-herpesviruses EBV and KSHV for pathogenesis.

Authors:  Fang Wei; Qing Zhu; Ling Ding; Qing Liang; Qiliang Cai
Journal:  Virol Sin       Date:  2016-09-12       Impact factor: 4.327

9.  Human Cytomegalovirus UL135 Interacts with Host Adaptor Proteins To Regulate Epidermal Growth Factor Receptor and Reactivation from Latency.

Authors:  Michael A Rak; Jason Buehler; Sebastian Zeltzer; Justin Reitsma; Belen Molina; Scott Terhune; Felicia Goodrum
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

10.  The KSHV K1 Protein Modulates AMPK Function to Enhance Cell Survival.

Authors:  Penny M Anders; Zhigang Zhang; Prasana M Bhende; Louise Giffin; Blossom Damania
Journal:  PLoS Pathog       Date:  2016-11-09       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.